KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $202,000 | -36.9% | 1,123 | -63.6% | 0.00% | -50.0% |
| Q2 2017 | $320,000 | +65.8% | 3,086 | +25.5% | 0.00% | +100.0% |
| Q1 2017 | $193,000 | +192.4% | 2,459 | +65.7% | 0.00% | +100.0% |
| Q4 2016 | $66,000 | -1.5% | 1,484 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $67,000 | +21.8% | 1,200 | +9.1% | 0.00% | 0.0% |
| Q2 2016 | $55,000 | +34.1% | 1,100 | +22.2% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -16.3% | 900 | +12.5% | 0.00% | 0.0% |
| Q4 2015 | $49,000 | +28.9% | 800 | +18.5% | 0.00% | 0.0% |
| Q3 2015 | $38,000 | +533.3% | 675 | +575.0% | 0.00% | – |
| Q2 2015 | $6,000 | -57.1% | 100 | -59.5% | 0.00% | – |
| Q1 2015 | $14,000 | – | 247 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |